About Candesant Biomedical
Candesant Biomedical is a private company based in Nashville, Tennessee. It has reported $44,494,307 raised in two offerings on Form D since February 2020. Its chief executive is Niquette Hunt.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 12, 2022 | Jun 6, 2023 | $35,360,875fully sold | 59 | $599K | EquityRule 506(b) | Form D ↗ |
| Feb 5, 2019 | Feb 18, 2020 | $9,133,432fully sold | 33 | $276K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $44,494,307 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Candesant Biomedical's Form D filed Jun 6, 2023.
KL
Karen Long
Director
BH
Brad Hauser
Director
NH
Niquette Hunt
President and Chief Executive Officer, director
MK
Mary Beth Kreissler
Executive officer
SB
Samara Braunstein
Director
MK
Michael Kane
Director
EM
Eileen McGuire
Director
Earlier filings also listed Robert Grove, Ph.D. (director, last listed Feb 2020), Michael Kane, M.D. (director, last listed Feb 2020) and Amy Schulman (director, last listed Feb 2020).